Key features and details
- Assay type: Cell-based (qualitative)
- Platform: Fluorescence microscope
- Sample type: Adherent cells, Suspension cells
製品名Phalloidin-iFluor 680 Reagent
F-actin キット 製品一覧
サンプルの種類Adherent cells, Suspension cells
Phalloidin-iFluor 680 Reagent (ab176760) is one of a series of phalloidin conjugates that bind to actin filaments, also known as F-actin. Phallodin-iFluor 680 can be detected with a fluorescent microscope at Ex/Em = 683/700 nm (NIR range).
Phalloidin conjugates are convenient probes for labeling, identifying and quantifying animal or plant actin filaments in formaldehyde-fixed and permeabilized tissue sections, cell cultures or cell-free experiments. They can also be used in paraffin-embedded samples that have been de-paraffinized.
Review our other popular phalloidin dye conjugates, including Phalloidin-iFluor 488, Phalloidin-iFluor 647, Phalloidin-iFluor 594, Phalloidin-iFluor 555, and Rhodamine Phalloidin, or search our website to see the rest of the range.
Staining fixed cell or tissue samples with phalloidin conjugates is very simple; it requires a single 20-90 min incubation with the phalloidin, followed by 3 short wash steps. Phalloidin staining can be combined with antibody-based staining by adding the phalloidin conjugate during either the primary or secondary antibody incubation step.
When used in unfixed samples, phalloidin binding leads to a decrease in the disassociation rate of actin subunits from the ends of actin filaments, essentially stabilizing actin filaments through the prevention of filament depolymerisation.
保存方法Store at -20°C. Please refer to protocols.
内容 300 tests Phalloidin-iFluor 680 Conjugate 1 x 300 tests
- actin filament
- f actin
- Filamentous actin
Actin filaments staining in HeLa cells. Actin filaments (red) were stained with CytoPainter Phalloidin-iFluor 680 reagent (ab176760). Nuclei were stained with Nuclear Green DCS1 (ab138905).
Excitation and emission spectra of phalloidin-iFluor 680 reagent.
ab176760 は 1 報の論文で使用されています。
- Herskovitz J et al. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination. EBioMedicine 73:103678 (2021). PubMed: 34774454